Can a fun virtual therapy platform keep kids engaged?

NCT ID NCT07155707

First seen Jun 26, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a new online therapy platform called Teleo, designed specifically for children with anxiety or mood disorders. Researchers want to see if kids are more engaged during therapy sessions on Teleo compared to standard video calls. About 156 children will take part, and their engagement will be measured through questionnaires and observation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Teleo virtual therapy platform
What this could lead to
If it works, this could show that a specially designed virtual platform helps children engage more in therapy, potentially improving mental health outcomes.
What could go wrong
This is an early Phase II trial with only 156 participants, so results may not apply to all children. The study measures engagement, not long-term symptom relief, and the platform may not outperform standard video.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ohana Center for Child and Adolescent Behavioral Health

    NOT_YET_RECRUITING

    Monterey, California, 93940, United States

  • Stanford University

    RECRUITING

    Stanford, California, 94305, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.